These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3080642)

  • 1. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
    Menon M; Drexler HG; Minowada J
    Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
    Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
    Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the immunologic classification of leukemia.
    Foon KA; Gale RP; Todd RF
    Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface marker expression of human B-cell lymphomas.
    Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.
    Anderson KC; Bates MP; Slaughenhoupt BL; Pinkus GS; Schlossman SF; Nadler LM
    Blood; 1984 Jun; 63(6):1424-33. PubMed ID: 6609729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
    Miller RA; Gralow J
    J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphomas associated with human T-cell leukemia-lymphoma virus may show phenotypic and functional differences from adult T-cell leukemias.
    Yamada Y; Amagasaki T; Kamihira S; Kinoshita K; Ikeda S; Kusano M; Suzuyama J; Toriya K; Tomonaga Y; Ichimaru M
    Clin Immunol Immunopathol; 1985 Sep; 36(3):306-19. PubMed ID: 2990783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.